Tenax Therapeutics, Inc. (TENX) Stock Overview
Explore Tenax Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Tenax Therapeutics, Inc. (TENX)
Key Financials
Key Financials
Market Cap
36.5M
P/E Ratio
-0.94
EPS (TTM)
$-1.40
ROE
-0.62%
TENX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Tenax Therapeutics, Inc. (NASDAQ: TENX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Tenax Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TENX on the NASDAQ shows an RSI of 16.80, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $10.85 for the NASDAQ listing.
Key metrics behind Tenax Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.94 and a market capitalization of 36.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TENX on the NASDAQ.